Wenyu Lin

Wenyu Lin has extensive work experience in the field of science, technology, and research. Wenyu'smost recent position was as an Associate Director in the CSO Office at Hummingbird Bioscience, which they started in July 2022. Prior to this, they worked at A*STAR - Agency for Science, Technology and Research, where they held the role of Deputy Director in the PharmBio Cluster from April 2021 to June 2022, and Head of the Health and Biomedical Cluster from February 2019 to March 2021. Before joining A*STAR, Wenyu worked at IPOS International as a Patent Examiner & Analyst from September 2013 to February 2019. Additionally, they served as a Research Fellow at A*STAR from February 2011 to September 2013.

Wenyu Lin holds a Doctor of Philosophy (Ph.D.) degree in Stem cell and immunology from Imperial College London, which was completed from 2006 to 2010. Prior to that, Wenyu Lin obtained a Bachelor of Science (Pharmacy)(Hons) degree in Pharmacy from the National University of Singapore, which was completed from 2001 to 2005. Wenyu Lin also attended Raffles Junior College, where they focused on Triple sciences, although the specific duration of attendance is not provided.